The company is pulling 534,000 Injekt Luer Solo and 604,800 Luer Lock Solo syringes in a Class II recall because “the sterile blister packaging may be damaged, and sterility may be compromised,” according to a Sept. 27 post from the FDA.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
